8 completed. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 3 | Completed 3 |
Follow ponezumab: new trials by email Literature Review of ponezumab trials Research Report on ponezumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy Ponezumab, placebo - Cerebral Amyloid Angiopathy | Phase 2 | Completed | Pfizer | 36 | 2013-06-01 | 2017-05-10 |
| Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease PF-04360365 8.5 mg/kg, Placebo - Alzheimer's Disease | Phase 1 | Completed | Pfizer | 8 | 2010-05-01 | 2011-08-12 |
| Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers PF-04360365, Placebo - Alzheimer's Disease | Phase 1 | Completed | Pfizer | 17 | 2010-03-01 | 2012-09-26 |
| A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease PF-04360365 10 mg/kg, PF-04360365 7.5 mg/kg, placebo - Alzheimer's Disease | Phase 2 | Completed | Pfizer | 36 | 2009-08-06 | 2024-04-19 |
| Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg - Alzheimer's Disease | Phase 2 | Completed | Pfizer | 198 | 2008-12-05 | 2022-11-07 |
| Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease PF-04360365 1 mg/kg, PF-04360365 3 mg/kg, PF-04360365 5 mg/kg - Alzheimer's Disease | Phase 1 | Completed | Pfizer | 15 | 2008-08-01 | 2009-07-28 |
| A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease PF-04360365, Placebo - Alzheimer's Disease | Phase 1 | Completed | Pfizer | 20 | 2008-02-01 | 2010-12-07 |
| A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease PF-04360365, Placebo - Alzheimer's Disease | Phase 1 | Completed | Pfizer | 37 | 2007-03-01 | 2009-10-14 |
Alzheimer Disease (7) · Cerebral Amyloid Angiopathy (1)
Pfizer (8)
United States (4) · Canada (3) · Sweden (3) · United Kingdom (3) · Australia (2) · Japan (2) · Belgium (1) · France (1) · Netherlands (1) · South Korea (1)
2008 (1), 2009 (1)